Fidelity Investments’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.2M | Buy |
11,102,770
+1,052,031
| +10% | +$3.62M | ﹤0.01% | 1479 |
|
|
2025
Q1 | $21.4M | Buy |
10,050,739
+23,438
| +0.2% | +$49.9K | ﹤0.01% | 1653 |
|
|
2024
Q4 | $32M | Buy |
10,027,301
+4,522,479
| +82% | +$14.4M | ﹤0.01% | 1560 |
|
|
2024
Q3 | $73.5M | Buy |
5,504,822
+5,370,392
| +3,995% | +$71.7M | ﹤0.01% | 1216 |
|
|
2024
Q2 | $1.34M | Buy |
+134,430
| New | +$1.34M | ﹤0.01% | 2440 |
|
|
2024
Q1 | – | Sell |
-20
| Closed | -$82 | – | 5295 |
|
|
2023
Q4 | $82 | Sell |
20
-1,780
| -99% | -$7.3K | ﹤0.01% | 4959 |
|
|
2023
Q3 | $4.93K | Buy |
1,800
+1,797
| +59,900% | +$4.92K | ﹤0.01% | 4333 |
|
|
2023
Q2 | $18 | Buy |
+3
| New | +$18 | ﹤0.01% | 5197 |
|
|
2023
Q1 | – | Sell |
-627
| Closed | -$1.55K | – | 5301 |
|
|
2022
Q4 | $1.55K | Buy |
+627
| New | +$1.55K | ﹤0.01% | 4567 |
|
|
2021
Q3 | – | Sell |
-6
| Closed | – | – | 4397 |
|
|
2021
Q2 | $0 | Buy |
+6
| New | – | ﹤0.01% | 4289 |
|
|
2019
Q4 | – | Sell |
-310
| Closed | -$1K | – | 3803 |
|
|
2019
Q3 | $1K | Buy |
+310
| New | +$1K | ﹤0.01% | 3625 |
|